Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cell Transplantation|September 9, 2017
Acute Lethal Injury of Lung and Liver in Mice Transplanted with Ex Vivo-Expanded CTLsTadayuki Sato, Kiyoshi Ando, Masayuki Oki, et al.
Experimental Hematology|October 19, 2006
Multipotent adult progenitor cell isolation and culture proceduresApril Breyer, Nima Estharabadi, Masayuki Oki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 30, 2004
[Cord blood transplantation supported with ex vivo expanded fraction for a patient with myelodysplastic syndrome and metastatic breast cancer]Masayuki Oki, Kiyoshi Ando, Hikaru Nakajima, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 6, 2017
A Case of Overwhelming Postsplenectomy Infection Caused by Streptococcus pneumoniae with Fulminant PurpuraMasamichi Komatsu, Toru Ishihara, Saki Manabe, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 6, 2017
Secondary Adrenal Insufficiency Following Nivolumab Therapy in a Patient with Metastatic Renal Cell CarcinomaToshiro Seki, Atsushi Yasuda, Masayuki Oki, et al.
The Tokai Journal of Experimental and Clinical Medicine|April 7, 2016
A Rare Case of Subclinical Primary Aldosteronism and Subclinical Cushing's Syndrome without Cardiovascular ComplicationsNatsumi Kitajima, Toshiro Seki, Atsushi Yasuda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 13, 2011
Disseminated mucormycosis infection after the first course of dose-modified R-EPOCH for advanced-stage lymphomaMasahito Itoh, Masayuki Oki, Hidetaka Yanagi, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 24, 2015
Disseminated mucormycosis infection after the first course of dose-modified R-EPOCH for advanced-stage lymphomaMasahito Itoh, Masayuki Oki, Hidetaka Yanagi, et al.
Experimental Hematology|September 13, 2002
Reconstitution of functional human B lymphocytes in NOD/SCID mice engrafted with ex vivo expanded CD34(+) cord blood cellsChenwgwen Li, Kiyoshi Ando, Yoshie Kametani, et al.
Pageof 4